Empowered Funds
LFCR icon

Empowered Funds’s Lifecore Biomedical LFCR Stock Holding History

Empowered Funds’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$309K Buy
+46,900
New +$217K ﹤0.01% 2025

Other funds holding LFCR

Greenhaven Road Investment Management
Greenhaven Road Investment Management Greenwich, Connecticut $130M AUM 16.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Quinn Opportunity Partners
Quinn Opportunity Partners Charlottesville, Virginia $1.85B AUM 1.27% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $444M AUM 151.5% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Empowered Funds's LFCR Position: Q3 2026 in Review

Empowered Funds opened a new position in Lifecore Biomedical (LFCR) in Q3 2026: 46,900 shares worth $309K. The stake represents ﹤0.01% of the portfolio and ranks #2025 among its holdings.

77 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.

  • Empowered Funds held 46,900 shares of Lifecore Biomedical worth $309K as of Q3 2026.
  • Lifecore Biomedical was a new Empowered Funds position in Q3 2026.
  • Lifecore Biomedical made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2025 holding.
  • 77 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.